Global Strategic Investment Solutions’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Global Strategic Investment Solutions’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-329	Closed	-$2.67K	–	147
2023 Q1	$2.67K	Hold	329	–	–	﹤0.01%	134
2022 Q4	$3.89K	Hold	329	–	–	﹤0.01%	128
2022 Q3	$5K	Hold	329	–	–	﹤0.01%	132
2022 Q2	$12K	Hold	329	–	–	﹤0.01%	123
2022 Q1	$13K	Hold	329	–	–	﹤0.01%	133
2021 Q4	$14K	Hold	329	–	–	﹤0.01%	136
2021 Q3	$22K	Hold	329	–	–	﹤0.01%	140
2021 Q2	$25K	Hold	329	–	–	﹤0.01%	137
2021 Q1	$22K	Hold	329	–	–	﹤0.01%	129
2020 Q4	$11K	Hold	329	–	–	﹤0.01%	99
2020 Q3	$18K	Hold	329	–	–	﹤0.01%	99
2020 Q2	$12K	Hold	329	–	–	﹤0.01%	90
2020 Q1	$8K	Hold	329	–	–	﹤0.01%	79
2019 Q4	$16K	Hold	329	–	–	0.01%	73
2019 Q3	$16K	Hold	329	–	–	0.01%	79
2019 Q2	$30K	Hold	329	–	–	0.02%	56
2019 Q1	$49K	Buy	+329	New	+$63.6K	0.03%	53

Other funds holding DMK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Global Strategic Investment Solutions's DMK Position: Q2 2023 in Review

Global Strategic Investment Solutions sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2023, closing a stake of 329 shares — an estimated $2.67K sold.

Global Strategic Investment Solutions first reported a position in DMK in Q1 2019 and held it in 17 quarters. The position peaked at $49K in Q1 2019. 22 funds tracked by Wall St. Rank hold DMK as of Q2 2023.

Global Strategic Investment Solutions reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2023 after selling out during the quarter.
Global Strategic Investment Solutions sold 329 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2023, an estimated $2.67K.
Global Strategic Investment Solutions first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2019 and held it in 17 quarters.
Global Strategic Investment Solutions's DMK Pharmaceuticals Corporation Common Stock position peaked at $49K in Q1 2019.
22 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2023.

Based on Global Strategic Investment Solutions's 13F filing for Q2 2023, filed 7 Aug 2023.